Dr. Martens plc (LON:DOCS – Get Free Report) reached a new 52-week low during trading on Thursday. The company traded as low as GBX 52.75 and last traded at GBX 54.25, with a volume of 49,082,344 shares. The stock had previously closed at GBX 65.
Wall Street Analyst Weigh In
Separately, Berenberg Bank restated a “buy” rating and set a GBX 110 target price on shares of Dr. Martens in a research note on Friday, October 9th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of GBX 105.
Get Our Latest Analysis on DOCS
Dr. Martens Stock Performance
The company has a market cap of £509.26 million, a PE ratio of 22.17, a PEG ratio of 6.40 and a beta of 0.26. The company has a current ratio of 2.61, a quick ratio of 1.13 and a debt-to-equity ratio of 108.85. The business’s 50 day moving average is GBX 67.13 and its two-hundred day moving average is GBX 69.53.
Dr. Martens (LON:DOCS – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported GBX (1) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 6.89% and a net margin of 3.11%. The business had revenue of £290.40 million during the quarter. On average, equities research analysts anticipate that Dr. Martens plc will post 2.58 EPS for the current year.
Insider Activity at Dr. Martens
In other news, insider Ije Nwokori sold 209,160 shares of the company’s stock in a transaction dated Friday, October 16th. The stock was sold at an average price of GBX 69, for a total value of £144,320.40. 2.97% of the stock is owned by insiders.
Dr. Martens Company Profile
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot – named after the date it was produced – rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, “Docs” or “DM’s” were later adopted by musicians and subcultural pioneers who took them from the street to the global stage. Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.
Read More
- Five stocks we like better than Dr. Martens
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
